3hc8
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Investigation of Aminopyridiopyrazinones as PDE5 Inhibitors: Evaluation of Modifications to the Central Ring System.== | ==Investigation of Aminopyridiopyrazinones as PDE5 Inhibitors: Evaluation of Modifications to the Central Ring System.== | ||
<StructureSection load='3hc8' size='340' side='right' caption='[[3hc8]], [[Resolution|resolution]] 1.79Å' scene=''> | <StructureSection load='3hc8' size='340' side='right' caption='[[3hc8]], [[Resolution|resolution]] 1.79Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3hc8]] is a 1 chain structure | + | <table><tr><td colspan='2'>[[3hc8]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HC8 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3HC8 FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=PD4:6-(6-METHOXYPYRIDIN-3-YL)-2-[(2-MORPHOLIN-4-YLETHYL)AMINO]-4-(2-PROPOXYETHYL)PYRIDO[2,3-B]PYRAZIN-3(4H)-ONE'>PD4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=PD4:6-(6-METHOXYPYRIDIN-3-YL)-2-[(2-MORPHOLIN-4-YLETHYL)AMINO]-4-(2-PROPOXYETHYL)PYRIDO[2,3-B]PYRAZIN-3(4H)-ONE'>PD4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2h40|2h40]], [[2h42|2h42]], [[2h44|2h44]], [[3bjc|3bjc]], [[1uho|1uho]], [[2chm|2chm]], [[3hdz|3hdz]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2h40|2h40]], [[2h42|2h42]], [[2h44|2h44]], [[3bjc|3bjc]], [[1uho|1uho]], [[2chm|2chm]], [[3hdz|3hdz]]</td></tr> | ||
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3hc8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hc8 OCA], [http://pdbe.org/3hc8 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3hc8 RCSB], [http://www.ebi.ac.uk/pdbsum/3hc8 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3hc8 ProSAT]</span></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3hc8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hc8 OCA], [http://pdbe.org/3hc8 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3hc8 RCSB], [http://www.ebi.ac.uk/pdbsum/3hc8 PDBsum]</span></td></tr> | + | |
</table> | </table> | ||
== Function == | == Function == | ||
Line 36: | Line 36: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: Human]] | ||
[[Category: Cubbage, J W]] | [[Category: Cubbage, J W]] | ||
[[Category: Hughes, R O]] | [[Category: Hughes, R O]] | ||
[[Category: Stallings, W C]] | [[Category: Stallings, W C]] | ||
[[Category: Williams, J M]] | [[Category: Williams, J M]] | ||
+ | [[Category: Alternative splicing]] | ||
[[Category: Camp]] | [[Category: Camp]] | ||
[[Category: Cgmp]] | [[Category: Cgmp]] | ||
Line 53: | Line 53: | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
[[Category: Polymorphism allosteric enzyme]] | [[Category: Polymorphism allosteric enzyme]] | ||
+ | [[Category: Zinc]] |
Revision as of 11:06, 3 August 2017
Investigation of Aminopyridiopyrazinones as PDE5 Inhibitors: Evaluation of Modifications to the Central Ring System.
|